Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 255-490-0 | CAS number: 41672-81-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11-12-2007 to 25-02-2008
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Test performed in 2008.
LLNA method (OECD 442 B) was adopted in 2010.
Test material
- Reference substance name:
- trans-1-(1-oxohexadecyl)-4-[(1-oxohexadecyl)oxy]-L-proline
- EC Number:
- 255-490-0
- EC Name:
- trans-1-(1-oxohexadecyl)-4-[(1-oxohexadecyl)oxy]-L-proline
- Cas Number:
- 41672-81-5
- Molecular formula:
- C37H69NO5
- IUPAC Name:
- 1-palmitoyl-4-(palmitoyloxy)-L-proline
- Details on test material:
- - form: power
- colour: white
- batch number: 0724300010
- re-test date: 30-08-2010
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- 15 female albino guinea pigs of Dunkin-Hartley strain, supplied by Charles River (F-69592 L’Arbresle) weighed between 252 and 297 at the beginning of the test and were 4 weeks old.
Prior to the test, the animals were kept for a minimum acclimatisation period of 5 days, under stabling and nutritional conditions identical to those of the test.
Before the experimentation process, they were identified individually by marking with picric acid and a tattoo placed on their ear.
The animals were carefully shorn before each test item application.
The animals were housed either in groups of 2 or 3 in polycarbonate containers, the flooring of which
was covered with dust-free cuttings and the top fitted a stainless steel lid with a feeding device and
drinking device of 500 ml.
The environmental parameters of the main test were :
- Temperature : between 20°C and 23°C
- Relative humidity : between 33% and 67%
- Lighting time: 12 hours daily
The drinking water (tap water from public distribution system) and food were supplied freely.
Microbiological verification and chemical analysis were conducted every six months by the Institut Européen de l’Environnement de Bordeaux (I.E.E.B.).
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- (1) Preliminary study
-determination by intrademal injection of the Maximal Non Necrotizing Concentration (MNNC): 0.0975% ; 0.195% ; 0.39% ; 0.78% ; 1.56% ; 3.125% ; 6.25% ; 12.5% ; 25% ; 50% in isotonic sodium cloride.
-determination by topical application of the Pre-Maximal Non Irritant Concentration (Pre-MNIC): 6.25% ; 12.5% ; 25% and 50% in distilled water.
-determination by topical application of the Maximal Non Irritant Concentration (MNIC): 6.25% ; 12.5%; 25% and 50% in distilled water.
(2) Main study
intradermal induction with the product at 0.78% in isotonic sodium chloride
topical induction with the product at 50% in distilled water
challenge with the product at 25% and 50% in distilled water
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- (1) Preliminary study
-determination by intrademal injection of the Maximal Non Necrotizing Concentration (MNNC): 0.0975% ; 0.195% ; 0.39% ; 0.78% ; 1.56% ; 3.125% ; 6.25% ; 12.5% ; 25% ; 50% in isotonic sodium cloride.
-determination by topical application of the Pre-Maximal Non Irritant Concentration (Pre-MNIC): 6.25% ; 12.5% ; 25% and 50% in distilled water.
-determination by topical application of the Maximal Non Irritant Concentration (MNIC): 6.25% ; 12.5%; 25% and 50% in distilled water.
(2) Main study
intradermal induction with the product at 0.78% in isotonic sodium chloride
topical induction with the product at 50% in distilled water
challenge with the product at 25% and 50% in distilled water
- No. of animals per dose:
- controls: 5 animals
treated: 10 animals - Details on study design:
- (1) Preliminary study
- for the determination of the MNNC, two animals received increasing concentration of the substance by intradermal injection on both sides of the spine. A macroscopic evaluation of the cutaneous reactions was conducted 24 hours later.
- for the determination of the pre-MNIC, the product was applied on the dorso-lumbar zone of 2 animals shorn beforhand, with occlusive dressing for 24 hours. A macroscopic evaluation of the cutaneous reactions was conducted 24 hours after removal of the dressing.
- for the determination of the MNIC, 3 animals were treated according to the same treatment as negative controls for the induction phase (ie 2 intradermic injection (ID) of Freund's Complete Adjuvant (FCA) diluted at 50% in isotonic sodium chloride + 2 ID of isotonic sodium chloride + 2 ID a mixture with equal volumes v/v FCA at 50% and isotonic sodium chloride. 7 days after, the animals were shared and a 24 hours topic application under occlusive dressing of the test product at 6.25% ; 12.5% ; 25% and 50% in distilled water was performed.
A macroscopic evaluation of the cutaneous reactions was conducted 24 hours after removal of the occlusive dressing.
(2) Main study
A- Induction
1st Intradermal Induction:
Day 0
After shearing the scapular zone, three (3) pairs of intradermal injections (ID) of 0.1 ml were performed on the scapular zone in such a way as an injection on each pair is placed to either side of the spine as follows :
GROUP 1 (Negative control):
• 2 ID: Freund’s Complete Adjuvant diluted at 50 % in isotonic sodium chloride.
• 2 ID: isotonic sodium chloride
• 2 ID: a mixture with equal volumes v/v :
- Freund’s Complete Adjuvant at 50% and isotonic sodium chloride,
GROUP 2 (Treated):
• 2 ID: Freund’s Complete Adjuvant diluted by 50 % in isotonic sodium chloride,
• 2 ID: test item at 0.78%,
• 2 ID a test mixture in equal volumes v/v :
- Freund’s Complete Adjuvant at 50% and the test item at 1.56%.
2nd Topical Induction:
Day 6
The scapular zone of all the animals in each group, shorn beforehand, was brushed with a solution of sodium lauryl sulfate at 10% in thick vaseline, in
order to create a local irritation.
Day 7
A topical application under occlusive dressing for 48 hours was performed on the injection sites of each animal.
GROUP 1 (Negative control): 0.5 ml of distilled water
GROUP 2 (treated): 0.5 ml of the test item at 50%
B - Rest phase
The animals of both groups were left for 10 days.
C - Challenge phase
Day 21
The experimental procedure of this phase was identical for both groups GROUP 1 (Negative control) and GROUP 2 (Treated) submitted to this experimentation: on the previously shorn dorso-lumbar zone, an application on either side of the spine, under occlusive dressing, was performed during 24 hours:
- 1 sample cup containing the test item at 50% (MNIC) and at 25% (1/2 MNIC). - Challenge controls:
- Negative controls : 5 animals
1st Intradermal Induction:
Day 0
After shearing the scapular zone, three (3) pairs of intradermal injections (ID) of 0.1 ml were performed on the scapular zone in such a way as an injection on each pair is placed to either side of the spine as follows :
GROUP 1 (Negative control):
• 2 ID: Freund’s Complete Adjuvant diluted at 50 % in isotonic sodium chloride.
• 2 ID: isotonic sodium chloride
• 2 ID: a mixture with equal volumes v/v :
- Freund’s Complete Adjuvant at 50% and isotonic sodium chloride,
2nd Topical Induction:
Day 6
The scapular zone of all the animals in each group, shorn beforehand, was brushed with a solution of sodium lauryl sulfate at 10% in thick vaseline, in order to create a local irritation.
Day 7
A topical application under occlusive dressing for 48 hours was performed on the injection sites of each animal.
GROUP 1 (Negative control): 0.5 ml of distilled water
Rest phase
The animals of control groups were left for 10 days.
Challenge phase
Day 21
The experimental procedure of this phase was identical for both groups GROUP 1 (Negative control) and GROUP 2 (Treated) submitted to this experimentation: on the previously shorn dorso-lumbar zone, an application on either side of the spine, under occlusive dressing, was performed during 24 hours:
- 1 sample cup containing the test item at 50% (MNIC) and at 25% (1/2 MNIC). - Positive control substance(s):
- yes
- Remarks:
- alpha-hexylcinnamaldehyde
Results and discussion
- Positive control results:
- positive control at 50% : 100% of animals sensitized after 24h
positive control at 50% : 90% of animals sensitized after 48h
positive control at 25% : between 90% and 100% of animals sensitized 24h
positive control at 25% : between 70% and 100% of animals sensitized 48h
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 25%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- Skin reaction
Score 1: 2 (treated groups 1 and 2), 0 (treated group 3)
Score 2: 1 (treated group 1), 8 (treated group 2), 7 (treated group 3)
Score 3: 0 (treated groups 1 and 2), 9 (treated group 3) - Remarks on result:
- other: Reading: 1st reading ; Hours after challenge: 24.0 ; Group: positive control ; Dose level: 25% ; No. with + reactions: 9 (treated group 1), 10 (treated groups 2 and 3) ; Total no. in group: 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 25%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- Skin reaction
Score 1: 6 (treated group1), 7 (treated groups 2 and 3)
Score 2: 3 (treated groups 1 and 3), 0 (treated group 2)
Score 3: 0 (treated groups 1, 2 and 3) - Remarks on result:
- other: Reading: 2nd reading ; Hours after challenge: 48.0 ; Group: positive control ; Dose level: 25% ; No. with + reactions: 9 (treated group 1), 7 (treated group 2, 10 (treated group 3) ; Total no. in group: 10
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 50%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- Skin reaction
Score 1: 2 (treated group 1), 1 (treated group 2), 0 (treated group 3)
Score 2: 5 (treated group 1), 9 (treated group 2), 0 (treated group 3)
Score 3: 3 (treated group 1), 0 (treated group 2), 10 (treated group 3) - Remarks on result:
- other: Reading: 1st reading ; Hours after challenge: 24.0 ; Group: positive control ; Dose level: 50% ; No. with + reactions: 10 (treated groups 1, 2 and 3) ; Total no. in group: 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 50%
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Clinical observations:
- Skin reaction
Score 1: 4 (treated group 1), 6 (treated group 2), 7 (treated group 3)
Score 2: 5 (treated group 1), 3 (treated group 2), 2 (treated group 3)
Score 3: 0 (treated group 1, 2 and 3) - Remarks on result:
- other: Reading: 2nd reading ; Hours after challenge: 48.0 ; Group: positive control ; Dose level: 50% ; No. with + reactions: 9 (treated groups 1, 2 and 3) ; Total no. in group: 10
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 2
- Total no. in group:
- 5
- Clinical observations:
- skin reaction score 1
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 50%. No with. + reactions: 2.0. Total no. in groups: 5.0. Clinical observations: skin reaction score 1.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 4
- Total no. in group:
- 10
- Clinical observations:
- skin reaction score 1
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50%. No with. + reactions: 4.0. Total no. in groups: 10.0. Clinical observations: skin reaction score 1.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 10.0.
Any other information on results incl. tables
The aim of the study was to evaluate the possible allergenic activity of the test substance after intradermic injection and topical administration in guinea pigs. After induction (intradermic injection at 0.78% and topical application at 50%) of 10 Guinea Pigs of treated group with the test item and a 10-day rest phase, the challenge phase, under occlusive dressing for 24 hours, consisted to a single topical application of the test item diluted at 50% and at 25% in distilled water. The experimental protocol was established according the O.E.C.D. guideline n°406 dated July 17th, 1992 and the method B.6 of the E.E.C. n°96/54 dated July 30th, 1996. Slight erythema was noted in 40% of the animals of the treated group (4/10) and of the animals of the control group (2/5), 24 hours after the challenge phase, on the treated area with the test item at 50%. These reactions were totally reversible at the reading time 48 hours and were significant of an irritant reaction type. No cutaneous intolerance reaction was recorded in the animals of the treated group, on the treated area at 25%. No cutaneous intolerance reaction was recorded in animals from the negative control group, on the treated area at 25%. In conclusion, in view of these results, under these experimental conditions, the test item LCA07033 must not be classified, in accordance with the criteria for classification, packaging and labelling of dangerous substances and preparations of the E.E.C. Directives 67/548, 2001/59 and 99/45. No symbol and risk phrase are required.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- In view of these results, under these experimental conditions, the test substance must not be classified, in accordance with the criteria for classification, packaging and labelling of dangerous substances and preparations of the E.E.C. Directives 67/548, 2001/59 and 99/45. No symbol and risk phrase are required.
- Executive summary:
The aim of the study was to evaluate the possible allergenic activity of the test substance after intradermic injection and topical administration in guinea pigs. After induction (intradermic injection at 0.78% and topical application at 50%) of 10 Guinea Pigs of treated group with the test item and a 10-day rest phase, the challenge phase, under occlusive dressing for 24 hours, consisted to a single topical application of the test item diluted at 50% and at 25% in distilled water. The experimental protocol was established according the O.E.C.D. guideline n°406 dated July 17th, 1992 and the method B.6 of the E.E.C. n°96/54 dated July 30th, 1996. Slight erythema was noted in 40% of the animals of the treated group (4/10) and of the animals of the control group (2/5), 24 hours after the challenge phase, on the treated area with the test item at 50%. These reactions were totally reversible at the reading time 48 hours and were significant of an irritant reaction type. No cutaneous intolerance reaction was recorded in the animals of the treated group, on the treated area at 25%. No cutaneous intolerance reaction was recorded in animals from the negative control group, on the treated area at 25%. In conclusion, in view of these results, under these experimental conditions, the test item LCA07033 must not be classified, in accordance with the criteria for classification, packaging and labelling of dangerous substances and preparations of the E.E.C. Directives 67/548, 2001/59 and 99/45. No symbol and risk phrase are required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.